High serum levels of free cortisol indicate severity of cirrhosis in hemodynamically stable patients

Journal of Gastroenterology and Hepatology (Australia)

Volumn 27, Issue 10, 2012, Pages 1596-1601

  Thevenot, Thierry ^a,b   Dorin, Richard ^e   Monnet, Elisabeth ^a,b   Qualls, Clifford R ^e   Sapin, Remy ^d   Grandclement, Emilie ^a   Borot, Sophie ^a   Sheppard, Frances ^c   Weil, Delphine ^a   Degand, Thibault ^a   Di Martino, Vincent ^a,b   Kazlauskaite, Rasa ^f  

^a UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^b UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^c HÔPITAL SAINT JACQUES   (France)

^d Université de Strasbourg Faculté de Psychologie   (France)

^e UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^f RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Adrenal insufficiency; Liver cirrhosis; Prognosis

Indexed keywords

ALBUMIN; BILIRUBIN; CREATININE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROCORTISONE;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; ASCITES; BILIRUBIN BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DEATH; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEMODYNAMICS; HUMAN; HUMAN TISSUE; HYDROCORTISONE BLOOD LEVEL; INTERNATIONAL NORMALIZED RATIO; KIDNEY FAILURE; LIVER CIRRHOSIS; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY;

EID: 84866559703     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2012.07188.x     Document Type: Article

References (24)

1. Fede G, Spadaro L, Tomaselli T etal. Assessment of adrenocortical reserve in stable patients with cirrhosis. J. Hepatol. 2011; 54: 243-50.
2. Fernandez J, Escorsell A, Zabalza M etal. Adrenal insufficiency in patients with cirrhosis and septic shock: effect of treatment with hydrocortisone on survival. Hepatology 2006; 44: 1288-95.
3. Galbois A, Rudler M, Massard J etal. Assessment of adrenal function in cirrhotic patients: salivary cortisol should be preferred. J. Hepatol. 2010; 52: 839-45.
4. Tan T, Chang L, Woodward A etal. Characterising adrenal function using directly measured plasma free cortisol in stable severe liver disease. J. Hepatol. 2010; 53: 841-8.
5. Thierry S, Giroux Leprieur E, Lecuyer L, Brocas E, Van de Louw A. Echocardiographic features, mortality, and adrenal function in patients with cirrhosis and septic shock. Acta Anaesthesiol. Scand. 2008; 52: 45-51.
6. Tsai MH, Peng YS, Chen YC etal. Adrenal insufficiency in patients with cirrhosis, severe sepsis and septic shock. Hepatology 2006; 43: 673-81.
7. Marik PE, Pastores SM, Annane D etal. Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit. Care Med. 2008; 36: 1937-49.
8. Kazlauskaite R, Evans AT, Villabona CV etal. Corticotropin tests for hypothalamic-pituitary- adrenal insufficiency: a metaanalysis. J. Clin. Endocrinol. Metab. 2008; 93: 4245-53.
9. Cooper MS, Stewart PM. Corticosteroid insufficiency in acutely ill patients. N. Engl. J. Med. 2003; 348: 727-34.
10. Thevenot T, Borot S, Remy-Martin A etal. Assessment of adrenal function in cirrhotic patients using concentration of serum-free and salivary cortisol. Liver Int. 2011; 31: 425-33.
11. Hamrahian AH, Oseni TS, Arafah BM. Measurements of serum free cortisol in critically ill patients. N. Engl. J. Med. 2004; 350: 1629-38.
12. Ren JC, Banan A, Keshavarzian A etal. Exposure to ethanol induces oxidative damage in the pituitary gland. Alcohol 2005; 35: 91-101.
13. Zapater P, Frances R, Gonzalez-Navajas JM etal. Serum and ascitic fluid bacterial DNA: a new independent prognostic factor in noninfected patients with cirrhosis. Hepatology 2008; 48: 1924-31.
14. Cervoni JP, Thévenot T, Weil D etal. C-reactive protein predicts short-term mortality in patients with end-stage liver disease. J. Hepatol. 2012; 56: 1299-304.
15. Stewart PM, Burra P, Shackleton CH, Sheppard MC, Elias E. 11 beta-Hydroxysteroid dehydrogenase deficiency and glucocorticoid status in patients with alcoholic and non-alcoholic chronic liver disease. J. Clin. Endocrinol. Metab. 1993; 76: 748-51.
16. Valentino R, Tommaselli AP, Savastano S etal. Alcohol inhibits 11-beta-hydroxysteroid dehydrogenase activity in rat kidney and liver. Horm. Res. 1995; 43: 176-80.
17. Ahmed A, Saksena S, Sherlock M, Olliff SP, Elias E, Stewart PM. Induction of hepatic 11beta-hydroxysteroid dehydrogenase type 1 in patients with alcoholic liver disease. Clin. Endocrinol. (Oxf) 2008; 68: 898-903.
18. Coolens JL, Van Baelen H, Heyns W. Clinical use of unbound plasma cortisol as calculated from total cortisol and corticosteroid-binding globulin. J. Steroid Biochem. 1987; 26: 197-202.
19. Dorin RI, Pai HK, Ho JT etal. Validation of a simple method of estimating plasma free cortisol: role of cortisol binding to albumin. Clin. Biochem. 2009; 42: 64-71.
20. Wade M, Baid S, Calis K, Raff H, Sinaii N, Nieman L. Technical details influence the diagnostic accuracy of the 1microg ACTH stimulation test. Eur. J. Endocrinol. 2010; 162: 109-13.
21. Beishuizen A, van Lijf JH, Lekkerkerker JF, Vermes I. The low dose (1microg) ACTH stimulation test for assessment of the hypothalamo-pituitary-adrenal axis. Neth. J. Med. 2000; 56: 91-9.
22. Christ-Crain M, Stolz D, Jutla S etal. Free and total cortisol levels as predictors of severity and outcome in community-acquired pneumonia. Am. J. Respir. Crit. Care Med. 2007; 176: 913-20.
23. Molenaar N, Johan Groeneveld AB, Dijstelbloem HM etal. Assessing adrenal insufficiency of corticosteroid secretion using free versus total cortisol levels in critical illness. Intensive Care Med. 2011; 37: 1986-93.
24. Marik PE, Gayowski T, Starzl TE. The hepatoadrenal syndrome: a common yet unrecognized clinical condition. Crit. Care Med. 2005; 33: 1254-9.